CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 24

Industry reads hand-picked by our editors

Mar 07, 2025

Science
Fifty years after ‘Asilomar,’ scientists meet again to debate biotech’s modern-day threats
MedTech Dive
FTC challenges $627M private equity takeover of Surmodics
The Wall Street Journal
RFK Jr.’s First Weeks as Trump’s Health Secretary Dominated by Secrecy and Turmoil

Mar 06, 2025

The Washington Post
Inside the scientific quest to reverse human aging
Axios
States push fight against mRNA vaccines
Politico
‘He needs to do much more’: RFK Jr.’s measles response under scrutiny

Mar 05, 2025

Associated Press
Trump’s FDA pick made his name by bashing the medical establishment. Soon he may be leading it
The Wall Street Journal
New Version of Merck’s Blockbuster Cancer Drug Threatened by Patent Battle
Fierce Biotech
DOGE terminates leases for 30 FDA sites across 23 states
Nature
Meet the ‘woolly mouse’: why scientists doubt it’s a big step towards recreating mammoths

Mar 04, 2025

The Wall Street Journal
RFK Jr.’s Health Department Heightens Scrutiny of Vaccines
Reuters
Bayer faces investors’ impatience ahead of fourth-quarter results
FirstWord Pharma
With Dupixent nipping at its heels, Novartis bets up to $777M on Kyorin’s itch candidate

Mar 03, 2025

Reuters
India’s Sun Pharma aims to launch its obesity drug in five years, managing director says
Axios
RFK Jr. move to kill public comment roils providers
Fierce Pharma
Lilly ads promote ‘healthy skepticism’ toward compounded drugs

Feb 28, 2025

The Atlantic
Inside the Collapse at the NIH
Reuters
Measles death in Texas puts Kennedy’s vaccine views to the test
Endpoints News
Trump’s science crackdown hits rare disease medicine: ‘We need to sit down with Elon Musk’

Feb 27, 2025

Bloomberg
Trump Team Considers Pulling Funding for Moderna Bird Flu Vaccine
C&EN
Amid deletions and lawsuits, groups race to save federal data
Fierce Pharma
Epidiolex maker Jazz reviewing M&A deal options of ‘various sizes,’ CFO says

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Trendline
The state of vaccine development in pharma Supported by Thermo Fisher Scientific
Trendline
The latest developments in oncology research Supported by CG Life
Trendline
Inside the market of emerging biotech Supported by Catalent

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
4 major trends shaping today’s oncology market Webinar - on demand • Provided by Advisory Board

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.